The Charity Bank Limited
Malcolm Hayday, FRSA, is the Chief Executive of The Charity Bank Limited, the UK’s first general charity to be authorised as a bank. He was previously the Director of Community Finance at CAF (Charities Aid Foundation) and Director of CAF’s social investment loan fund, Investors in Society. He is in his second term (1996-2002) (2004-) as a Board Member of INAISE, the International Association of Investors in the Social Economy, having been its President, 1997-2001. Since 2000 he has also been a Trustee of The Big Issue Foundation and was elected its Chairman in 2003. From 2002 to 2003 he was a founding Board member of the Community Development Finance Association (CDFA). He is a member of the Advisory Group of global foundation leaders to the World Economic Forum. Malcolm is also a member of the International Advisory Committee of NESsT, the non profit enterprise and self-sustainability team, and the Advisory Group for NCVO’s Sustainable Funding Project. He is the Accountable Officer to the Home Office for the Futurebuilders Fund. He is a Fellow of the Royal Society for the Arts. He graduated from Exeter University in 1972 with a BA Hons. in Economics. He joined CAF in 1993 to establish the loans service for charities. He has written a number of papers on the social economy and social investment.
Founder and CEO
Dr. Hale is the Founder of Medicines360, a pharmaceutical scientist and global health social entrepreneur. Her passion is the development of important new medicines for all of humanity, with the specific goal to reduce health inequities. Dr. Hale is Founder & Chair Emeritus of One World Health, the first nonprofit pharmaceutical company in the US. She founded the company in 2000 and served as its first Chairman and CEO (2000-2008). Under her leadership the organization developed a new cure for visceral leishmaniasis, launched a novel approach to treat dehydrating diarrhea, and developed a platform technology to reduce the cost of malaria drugs by more than 10-fold. Dr. Hale established her expertise in all stages of biopharmaceutical drug development at the US Food and Drug Administration (FDA), and at Genentech. She earned her PhD in Pharmaceutical Chemistry from University of California San Francisco, where she presently maintains an Adjunct Associate Professorship in Biopharmaceutical Sciences. Her recent honors include being elected to membership in the Institute of Medicine of the US National Academies (2007), and being granted the MacArthur “Genius” Award (2006). She received the President’s Award of Distinction from the American Association of Pharmaceutical Scientists. She is internationally recognized as a senior social entrepreneur by the Skoll Foundation, Schwab Foundation, and Ashoka. The Economist named Hale the recipient of its Social and Economic Innovation Award (2005).
Sustainable Healthcare Foundation
Liza Kimbo started her career in banking, and was Head of Division for Business Support Services at Standard Chartered Bank in Kenya. She then established a private retail pharmaceutical and distribution company with annual turnover of $1m in Nairobi. Liza has chaired two national advocacy groups: one that successfully influenced government policy for increased access to essential drugs; the other bringing together and strengthening civil society representatives working on malaria to participate in policy and national funding for the disease. Liza has worked for the last seven years to establish an innovative essential healthcare delivery organisation, CFWshops, using a franchise model. CFWshops currently operates 64 health outlets in ten districts in Kenya, and has provided over 1 million treatments to community members. In 2007 she joined Academy for Educational Development as the Regional Representative.
Global Head, Water
International Finance Corporation
Usha Rao-Monari is the Global Head of Water and Environment in the Infrastructure Department of International Finance Corporation (IFC). Since joining IFC she gained substantial experience in the Infrastructure, Manufacturing and Petrochemicals sectors worldwide. Rao-Monari was the Regional Manager for Manufacturing and Services for South Asia and Country Head for India, from 1998 to 2001 when she assumed her current responsibility in Washington, DC. Prior to joining IFC, she was a Vice President at Prudential-Bache Capital Funding.
Dr. Diana Wells, President of Ashoka, joined the organisation in the 1980s after graduating from Brown University with a degree in South Asian Studies. After taking a leave to pursue a Ph.D. in anthropology, Diana returned to Ashoka to provide leadership for the worldwide process of sourcing and selecting leading social entrepreneurs. She has contributed to the field of social entrepreneurship by implementing a widely respected tool for Measuring Effectiveness.
Dr Xiaolan Fu
SL Programme for Technology and Management for Development, University Lecturer in Development Studies, University of Oxford
Xiaolan Fu is Director of the Technology and Management for Development Programme, University Lecturer in Development Studies and Fellow of Green Templeton College. She is also project co-leader of several EPSRC and ESRC funded projects. She received the European Commission Gate2Growth 2005 'European Best Paper' Award, and has conducted consultancy research for ILO, UNCTAD, UNIDO, UKTI and the Chinese government. Dr Fu serves on the Advisory Expert Group of the OECD Global Investment Forum and is President of the Chinese Economic Association (Europe) and CEA (UK). She is also a Senior Research Associate at the University of Cambridge and University of Tsinghua, and a Visiting Professor at Guangdong University of Foreign Studies. As a leading China expert, she has participated in various interviews and panel discussions at main stream media including BBC Newsnight, BBC News, BBC Radio 2, Sky News and China Radio International.